Results

Total Results: 258 records

Showing results for "end stage renal".

101. Strategies for Patient, Family and Caregiver Engagement | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/family-engagement/protocol
     November 27, 2019 - ” [tiab] OR “end of life”[tiab] OR terminal care [mh] OR Palliative Care [mh] OR “patient safety”[tiab … ” [tiab] OR “end of life”[tiab] OR terminal care [mh] OR Palliative Care [mh] OR “patient safety”[tiab … stage renal disease, US-United States  2. … Will the Affordable Care Act Move Patient-Centeredness to Center Stage? 2012. … files/publication/25191/412525-Summary-Will-the-Affordable-Care-Act-Move-Patient-Centeredness-to-Center-Stage

102. Pressure-Ulcer-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
     May 01, 2013 - race/ ethnicity, socioeconomic status, and diverse specific medical comorbidities (e.g., diabetes, end-stage … renal disease, dementia), many Key Informants suggested that we include specific known risk factors … race/ethnicity, socioeconomic status, and diverse specific medical comorbidities (e.g., diabetes, end-stage … renal disease, and dementia), as well as patients with specific known risk factors for pressure ulcers … Stage I is defined as superficial erythema, stage II as partial thickness ulceration, stage III as

103. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
     June 01, 2015 -  High-Impact Potential: Lower end of the high-impact-potential range Gout Gout is the most prevalent …  High-Impact Potential: Lower end of the high-impact-potential range Psoriatic Arthritis Psoriatic …  High-Impact Potential: Lower end of the high-impact-potential range 1 Ankylosing Spondylitis … organic anion transporter involved in controlling the reabsorption of uric acid from the proximal renal … However, better gout management could reduce hospitalizations and renal or cardiovascular complications

104. Peripheral-Artery-Disease-Treatment Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
     January 31, 2013 - shares similar risk factors: male gender, age, diabetes, smoking, hypertension, high cholesterol, and renal … Fontaine classification Stage I No symptoms Stage IIa Intermittent claudication > 200m of walking … Stage 3 Rest pain Stage 4 Necrosis/gangrene Table 2. … Rutherford classification Stage 0 Asymptomatic Stage 1 Mild claudication Stage 2 Moderate claudication … Stage 3 Severe claudication Stage 4 Rest pain Stage 5 Ischemic ulceration not exceeding ulcer of

105. Comparative Effectiveness of Treatment for Hepatitis C in Adults | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hepatitis-c/research-protocol
     November 30, 2011 - according to patient subgroup characteristics, including but not limited to HCV genotype, age, race, sex, stage … harms differ according to patient subgroup characteristics, including HCV genotype, age, race, sex, stage … load, weight) Exclusions: pregnant women, HIV co-infection, transplant recipients, and patients with renal … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

106. Technical Brief 13: Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
     December 01, 2012 - To that end, advances in molecular and genomic medicine, such as gene expression profiling, may improve … underestimation of the tumor genomic landscape from analysis of multiple samples from patients with primary renal … 1) and stage D (Stage IV) colorectal cancer. … A or stage D. … T-stage, N-stage and MSI status.

107. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
     January 10, 2012 - Adjunct for the prevention of rejection in renal homotransplantation; management of active rheumatoid … (Hoffmann-La Roche) Prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac … Prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac, or hepatic transplants … Key Informants Key Informants are the end users of research, including patients and caregivers, … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

108. Disposition of Comments for CERs 155 156 Contast-Induced Nephropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
     January 07, 2016 - On page 20 lines 5-13, this topic is finally broached at the end of the "Future Research" section. … We know that CIN incidence varies dramatically based on baseline renal function, and the absence of … contrast-induced nephropathy (CIN), for the outcomes of incidence of CIN, chronic kidney disease (CKD), end … stage renal disease (ESRD), mortality, and other adverse events? … Need for renal replacement therapy is addressed in all comparisons.

109. Diabetes-Foot-Ulcer-Amputation-Prevalence Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
     February 01, 2011 - Those with diabetes are expected to suffer from several associ- ated medical complications, such as renal … The prevalence of LEA in nonelderly diabetics with PAD (many of whom likely have end-stage renal disease

110. Diabetes-Foot-Ulcer-Amputation-Incidence Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
     January 01, 2011 - amputation 2 People with diabetes often experience sev- eral associated medical complications, such as renal … The latter set of ICD-9 codes represents the following microvascular diseases: diabetic renal disease … Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population.

111. Disposition of Comments for CER 176 Management of Gout (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
     March 15, 2016 - accepted the target serum uric acid (SUA) levels (as opposed to gout flare reduction) as their primary end-points … We have modified the text on use in renal impairment. … However, what is the stage before the acute arthritis stage? Asympotmatic hyperuricemia? … disease, and of intervening upon hyperuricemia demonstrating renal benefits. … These decisions were made at the Topic Refinement stage.

112. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_research-protocol.pdf
     November 30, 2011 - harms differ according to patient subgroup characteristics, including HCV genotype, age, race, sex, stage … non-black); sex; stage of disease (e.g., cirrhosis or fibrosis); others (e.g., baseline viral load, … weight)  Exclusions: pregnant women, HIV co-infection, transplant recipients, and patients with renal … Key Informants Key Informants are the end users of research, including patients and caregivers, … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

113. Treatment for Restless Legs Syndrome: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs-future_research.pdf
     February 01, 2013 - No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically … RLS is unknown, but the disorder also occurs secondary to other conditions such as iron deficiency, end-stage … No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically excluded … - Stage Renal Disease Requiring Hemodialysis Drug: Rotigotine; Placebo NCT00258492 RLS Syndrome … Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole Drug: ropinirole dosing

114. A total of 1,364 patients were treated with a neurothrombectomy device as part of X reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/advanced-care-decision-aids_technical-brief.pdf
     July 01, 2014 - Potential outcome measure by stage .................................................................. … Characteristics associated with ACP at various stages Stage of Health/Illness Healthy Potentially … domain: the interactive CD-ROM,32 the enhanced information aid,25 a Web site intervention in pilot stage … Potential outcome measure by stage Outcome Stage of Health / Illness Healthy Potentially Life Threatening … Paradigm Task Force Ottawa Patient Decision Aid Research Group PBS Religion & Ethics Newsweekly Renal

115. Stroke Prevention in Atrial Fibrillation | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/stroke-atrial-fibrillation/research-protocol
     January 30, 2012 - We will monitor the number of articles excluded at the abstract stage for English language and determine … Food and Drug Administration; HAS-BLED = hypertension, abnormal renal/liver function, stroke, bleeding … At the full-text screening stage, two independent reviewers must agree on a final inclusion/exclusion … Key Informants Key Informants are the end-users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

116. Disposition of Comments Report for Nitrous Oxide for the Management of Labor Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_disposition-comments.pdf
     August 23, 2012 - TENS is only used for first stage labor. … third stage boxes. … labor, length of second-stage labor, and length of third- stage labor. … Section Comment Response Reviewer #11 Results Biochemical Findings, p. 58: Since the main data are re renal … Footnotes are listed at the end of each table.

117. Meeting Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
     January 01, 2011 - Collaborating with patient and consumer representatives at each stage in the research process improves … Toward that end, the expected role and required training of representatives should be clearly established … Presenting a clear timeline and anticipated time commitment at each stage of the project is also … Collyar President, Patient Advocates in Research (PAIR) Virna Elly Patient Advocate, Mid-Atlantic Renal

118. Vte-Prophyalaxis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_executive.pdf
     May 01, 2013 - failure, chronic renal failure, or end-stage renal disease. 22-25 Some of these patient groups have … impairment, or severe renal impairment not undergoing dialysis and patients receiving dialysis? … impairment, severe renal impairment, and renal replacement therapy (KQ 8) Special Populations (Timing … impairment, severe renal impairment, renal replacement therapy • Animal studies/models • Children … CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency.

119. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
     January 30, 2012 - We will monitor the number of articles excluded at the abstract stage for English language and determine … Food and Drug Administration; HAS-BLED = hypertension, abnormal renal/liver function, stroke, bleeding … At the full-text screening stage, two independent reviewers must agree on a final inclusion/exclusion … Key Informants Key Informants are the end-users of research, including patients and caregivers, practicing … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

120. Plasma-Cell-Dyscrasias-Sflc-Assay Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
     August 01, 2012 - Informants included representatives from the American Association for Clinical Chemistry; experts in renal … The other study, of C quality, compared the SFLC ratio with clinical stage (per Durie– Salmon staging … from already diagnosed patients could potentially bias the evidence, as they reflect the extreme end … reporting standards and a paucity of information regarding high-risk subgroups such as patients with renal … Serum free light chain measurements move to center stage.